Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 294

Related Citations for PubMed (Select 18369175)

1.

Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review.

O'Donnell MJ, Hankey GJ, Eikelboom JW.

Stroke. 2008 May;39(5):1638-46. doi: 10.1161/STROKEAHA.107.497271. Epub 2008 Mar 27. Review. Erratum in: Stroke. 2008 Sep;39(9): e147.

2.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
3.
5.

Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.

Hankey GJ, Eikelboom JW.

Neurology. 2005 Apr 12;64(7):1117-21. Review.

PMID:
15824331
6.

Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?

Diener HC.

Int J Stroke. 2006 Feb;1(1):4-8. doi: 10.1111/j.1747-4949.2005.00016.x.

PMID:
18706062
7.

Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.

Bath PM, Cotton D, Martin RH, Palesch Y, Yusuf S, Sacco R, Diener HC, Estol C, Roberts R; PRoFESS Study Group.

Stroke. 2010 Apr;41(4):732-8. doi: 10.1161/STROKEAHA.109.564906. Epub 2010 Feb 24.

8.

Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.

Jamieson DG, Parekh A, Ezekowitz MD.

J Cardiovasc Pharmacol Ther. 2005 Sep;10(3):153-61. Review.

PMID:
16211203
9.

Antiplatelet therapy for stroke prevention.

Hankey GJ.

Curr Atheroscler Rep. 2007 Oct;9(4):312-8. Review.

PMID:
18173959
10.

Antiplatelet agents and randomized trials.

Diener HC.

Rev Neurol Dis. 2007 Fall;4(4):177-83. Review.

PMID:
18195669
11.
12.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

13.

Antiplatelet drugs for ischemic stroke prevention.

Leys D, Balucani C, Cordonnier C.

Cerebrovasc Dis. 2009;27 Suppl 1:120-5. doi: 10.1159/000200449. Epub 2009 Apr 3. Review.

PMID:
19342841
14.

Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.

Coccheri S.

Drugs. 2010 May 7;70(7):887-908. doi: 10.2165/11536000-000000000-00000. Review.

PMID:
20426498
15.

Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

Kirshner HS.

Int J Clin Pract. 2007 Oct;61(10):1739-48. Review. Erratum in: Int J Clin Pract. 2007 Nov;61(11):1957.

16.

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P; American College of Chest Physicians.

Chest. 2008 Jun;133(6 Suppl):630S-669S. doi: 10.1378/chest.08-0720.

PMID:
18574275
17.

Aggrenox: a fixed-dose combination of aspirin and dipyridamole.

Lenz TL, Hilleman DE.

Ann Pharmacother. 2000 Nov;34(11):1283-90. Review.

PMID:
11098344
18.

Evolving perspectives on clopidogrel in the treatment of ischemic stroke.

Gorelick P, Sechenova O, Hennekens CH.

J Cardiovasc Pharmacol Ther. 2006 Dec;11(4):245-8. Review.

PMID:
17220470
19.

Dual antiplatelet therapy for prevention of recurrent ischemic events.

Nappi J, Talbert R.

Am J Health Syst Pharm. 2002 Sep 15;59(18):1723-35. Review.

PMID:
12298110
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk